|
1
|
Dela Cruz CS, Tanoue LT and Matthay RA:
Lung cancer: Epidemiology, etiology, and prevention. Clin Chest
Med. 32:605–644. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Herbst RS, Heymach JV and Lippman SM: Lung
cancer. N Engl J Med. 359:1367–1380. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Moro-Sibilot D, Smit E, de Castro Carpeño
J, Lesniewski- Kmak K, Aerts J, Villatoro R, Kraaij K, Nacerddine
K, Dyachkova Y, Smith KT, et al: Outcomes and resource use of
non-small-cell lung cancer (NSCLC) patients treated with first-line
platinum-based chemotherapy across Europe: FRAME prospective
observational study. Lung Cancer. 88:215–222. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Coussens LM and Werb Z: Inflammation and
cancer. Nature. 420:860–867. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
McMillan DC: Systemic inflammation,
nutritional status and survival in patients with cancer. Curr Opin
Clin Nutr Metab Care. 12:223–226. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gu XB, Tian T, Tian XJ and Zhang XJ:
Prognostic significance of neutrophil-to-lymphocyte ratio in
non-small-cell lung cancer: A meta-analysis. Sci Rep. 5:124932015.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang H, Gao L, Zhang B, Zhang L and Wang
C: Prognostic value of platelet to lymphocyte ratio in
non-small-cell lung cancer: A systematic review and meta-analysis.
Sci Rep. 6:226182016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li W, Ma G, Wu Q, Deng Y, Liu Y and Wang
J: Prognostic value of lymphocyte-to-monocyte ratio among Asian
lung cancer patients: A systematic review and meta-analysis.
Oncotarget. 8:110606–110613. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yuan C, Li N, Mao X, Liu Z, Ou W and Wang
SY: Elevated pretreatment neutrophil/white blood cell ratio and
monocyte/lymphocyte ratio predict poor survival in patients with
curatively resected non-small-cell lung cancer: Results from a
large cohort. Thorac Cancer. 8:350–358. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Feng F, Sun L, Zheng G, Liu S, Liu Z, Xu
G, Guo M, Lian X, Fan D and Zhang H: Low lymphocyte-to-white blood
cell ratio and high monocyte-to-white blood cell ratio predict poor
prognosis in gastric cancer. Oncotarget. 8:5281–5291. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Oken MM, Creech RH, Tormey DC, Horton J,
Davis TE, McFadden ET and Carbone PP: Toxicity and response
criteria of the Eastern Cooperative Oncology Group. Am J Clin
Oncol. 5:649–655. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Groome PA, Bolejack V, Crowley JJ, Kennedy
C, Krasnik M, Sobin LH and Goldstraw P; IASLC International Staging
Committee; Cancer Research and Biostatistics; Observers to the
Committee; Participating Institutions, : The IASLC Lung Cancer
Staging Project: Validation of the proposals for revision of the T,
N, and M descriptors and consequent stage groupings in the
forthcoming (seventh) edition of the TNM classification of
malignant tumours. J Thorac Oncol. 2:694–705. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Losada B, Guerra JA, Malón D, Jara C,
Rodriguez L and Del Barco S: Pretreatment neutrophil/lymphocyte,
platelet/lymphocyte, lymphocyte/monocyte, and neutrophil/monocyte
ratios and outcome in elderly breast cancer patients. Clin Transl
Oncol. 21:855–863. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang L, Liang D, Xu X, Jin J, Li S, Tian
G, Gao Z, Liu C and He Y: The prognostic value of neutrophil to
lymphocyte and platelet to lymphocyte ratios for patients with lung
cancer. Oncol Lett. 14:6449–6456. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ma JY and Liu Q: Clinicopathological and
prognostic significance of lymphocyte to monocyte ratio in patients
with gastric cancer: A meta-analysis. Int J Surg. 50:67–71. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang Y, Lu JJ, Du YP, Feng CX, Wang LQ
and Chen MB: Prognostic value of neutrophil-to-lymphocyte ratio and
platelet-to-lymphocyte ratio in gastric cancer. Medicine
(Baltimore). 97:e01442018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ying HQ, Deng QW, He BS, Pan YQ, Wang F,
Sun HL, Chen J, Liu X and Wang SK: The prognostic value of
preoperative NLR, d-NLR, PLR and LMR for predicting clinical
outcome in surgical colorectal cancer patients. Med Oncol.
31:3052014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cananzi FCM, Minerva EM, Samà L, Ruspi L,
Sicoli F, Conti L, Fumagalli Romario U and Quagliuolo VL:
Preoperative monocyte-to-lymphocyte ratio predicts recurrence in
gastrointestinal stromal tumors. J Surg Oncol. 119:12–20. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Feng F, Tian Y, Liu S, Zheng G, Liu Z, Xu
G, Guo M, Lian X, Fan D and Zhang H: Combination of PLR, MLR, MWR,
and tumor size could significantly increase the prognostic value
for gastrointestinal stromal tumors. Medicine (Baltimore).
95:e32482016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Quigley DA and Kristensen V: Predicting
prognosis and therapeutic response from interactions between
lymphocytes and tumor cells. Mol Oncol. 9:2054–2062. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang SC, Chou JF, Strong VE, Brennan MF,
Capanu M and Coit DG: Pretreatment neutrophil to lymphocyte ratio
independently predicts disease-specific survival in resectable
gastroesophageal junction and gastric adenocarcinoma. Ann Surg.
263:292–297. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Salazar-Onfray F, López MN and
Mendoza-Naranjo A: Paradoxical effects of cytokines in tumor immune
surveillance and tumor immune escape. Cytokine Growth Factor Rev.
18:171–182. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang L, Conejo-Garcia JR, Katsaros D,
Gimotty PA, Massobrio M, Regnani G, Makrigiannakis A, Gray H,
Schlienger K, Liebman MN, et al: Intratumoral T cells, recurrence,
and survival in epithelial ovarian cancer. N Engl J Med.
348:203–213. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang LN, Xiao W, OuYang PY, You K, Zeng
ZF, Ding PR, Pan ZZ, Xu RH and Gao YH: The prognostic impact of
preoperative blood monocyte count in pathological T3N0M0 rectal
cancer without neoadjuvant chemoradiotherapy. Tumour Biol.
36:8213–8219. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wen J, Ye F, Huang X, Li S, Yang L, Xiao X
and Xie X: Prognostic significance of preoperative circulating
monocyte count in patients with breast cancer: Based on a Large
Cohort Study. Medicine (Baltimore). 94:e22662015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lindholm PF, Sivapurapu N, Jovanovic B and
Kajdacsy-Balla A: Monocyte-induced prostate cancer cell invasion is
mediated by chemokine ligand 2 and nuclear factor-κB activity. J
Clin Cell Immunol. 6:3082015.PubMed/NCBI
|
|
27
|
Gabrilovich DI and Nagaraj S:
Myeloid-derived suppressor cells as regulators of the immune
system. Nat Rev Immunol. 9:162–174. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Mantovani A, Schioppa T, Porta C, Allavena
P and Sica A: Role of tumor-associated macrophages in tumor
progression and invasion. Cancer Metastasis Rev. 25:315–322. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ikemoto S, Sugimura K, Yoshida N, Wada S,
Yamamoto K and Kishimoto T: TNF alpha, IL-1 beta and IL-6
production by peripheral blood monocytes in patients with renal
cell carcinoma. Anticancer Res. 20:317–321. 2000.PubMed/NCBI
|
|
30
|
Mantovani A, Allavena P, Sica A and
Balkwill F: Cancer-related inflammation. Nature. 454:436–444. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kolaczkowska E and Kubes P: Neutrophil
recruitment and function in health and inflammation. Nat Rev
Immunol. 13:159–175. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
32
|
Tan KW, Chong SZ, Wong FH, Evrard M, Tan
SM, Keeble J, Kemeny DM, Ng LG, Abastado JP and Angeli V:
Neutrophils contribute to inflammatory lymphangiogenesis by
increasing VEGF-A bioavailability and secreting VEGF-D. Blood.
122:3666–3677. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Bausch D, Pausch T, Krauss T, Hopt UT,
Fernandez-del- Castillo C, Warshaw AL, Thayer SP and Keck T:
Neutrophil granulocyte derived MMP-9 is a VEGF independent
functional component of the angiogenic switch in pancreatic ductal
adenocarcinoma. Angiogenesis. 14:235–243. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kay HD and Smith DL: Regulation of human
lymphocyte-mediated natural killer (NK) cell activity. I.
Inhibition in vitro by peripheral blood granulocytes. J Immunol.
130:475–483. 1983.PubMed/NCBI
|
|
35
|
Petrie HT, Klassen LW and Kay HD:
Inhibition of human cytotoxic T lymphocyte activity in vitro by
autologous peripheral blood granulocytes. J Immunol. 134:230–234.
1985.PubMed/NCBI
|
|
36
|
el-Hag A and Clark RA: Immunosuppression
by activated human neutrophils. Dependence on the myeloperoxidase
system. J Immunol. 139:2406–2413. 1987.PubMed/NCBI
|
|
37
|
Shau HY and Kim A: Suppression of
lymphokine-activated killer induction by neutrophils. J Immunol.
141:4395–4402. 1988.PubMed/NCBI
|
|
38
|
Templeton AJ, McNamara MG, Šeruga B,
Vera-Badillo FE, Aneja P, Ocaña A, Leibowitz-Amit R, Sonpavde G,
Knox JJ, Tran B, et al: Prognostic role of neutrophil-to-lymphocyte
ratio in solid tumors: A systematic review and meta-analysis. J
Natl Cancer Inst. 106:dju1242014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Peng B, Wang YH, Liu YM and Ma LX:
Prognostic significance of the neutrophil to lymphocyte ratio in
patients with non-small-cell lung cancer: A systemic review and
meta-analysis. Int J Clin Exp Med. 8:3098–3106. 2015.PubMed/NCBI
|
|
40
|
Xin-Ji Z, Yong-Gang L, Xiao-Jun S, Xiao-Wu
C, Dong Z and Da-Jian Z: The prognostic role of neutrophils to
lymphocytes ratio and platelet count in gastric cancer: A
meta-analysis. Int J Surg. 21:84–91. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Rachidi S, Metelli A, Riesenberg B, Wu BX,
Nelson MH, Wallace C, Paulos CM, Rubinstein MP, Garrett-Mayer E,
Hennig M, et al: Platelets subvert T cell immunity against cancer
via GARP-TGFβ axis. Sci Immunol. 2:eaai79112017. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Majeti BK, Lee JH, Simmons BH and Shojaei
F: VEGF is an important mediator of tumor angiogenesis in malignant
lesions in a genetically engineered mouse model of lung
adenocarcinoma. BMC Cancer. 13:2132013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Qiang G, Liang C, Xiao F, Yu Q, Wen H,
Song Z, Tian Y, Shi B, Guo Y and Liu D: Prognostic significance of
platelet-to-lymphocyte ratio in non-small-cell lung cancer: A
meta-analysis. Onco Targets Ther. 9:869–876. 2016. View Article : Google Scholar : PubMed/NCBI
|
